ArticleScience translational medicine2019

Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates.

Leigh Goedeke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.